Latest Blogs

Jan 25, 2021
I’ve been thinking about the word “performance” a lot lately. Why is sexual activity described this way? 
Jan 19, 2021
Do you need to do an advanced fellowship? Dr. Samer Al Hadidi explores the opportunities and drawbacks, and acknowledges that in the current system, the answer is, "It depends."  
Jan 15, 2021
In this new year we must remain alert to our own prejudices, and be vigilant about keeping our personal biases out of the charts and out of our discussions with colleagues, patients, and caregivers. 
Jan 15, 2021
It was clear to chief medical officer Dr. Richard L. Schilsky that ASCO would be his professional home throughout his career. He shares reflections on the role of the Society ahead of his retirement, after 8 years as CMO, in February.
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is a professor of medicine at Brown University, director of the Breast and Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon across social media channels @drdonsdizon. 

Disclosure.

Dec 27, 2011
Around this time each year I find myself thinking about patients usually—and especially those that have passed away. I wonder how their families are coping, how their children are, and whether each day has gotten easier. I think about how my patients died—and whether or not I did enough to ensure...
Dec 06, 2011
Every once in a while I get an opportunity to speak at a meeting in which oncologists are not the primary audience. Of course, it is always to speak on either gynecologic- or breast-cancer-specific issues, but I always welcome the opportunity to educate a non-oncology audience about what we can do...
Oct 29, 2011
I was recently asked to comment on a study that sought to address the risk of ovarian cancer in women who undergo in vitro...
Oct 22, 2011
I was recently interviewed about breast cancer in young women, spurred by the recent disclosure that Giuliana Rancic, of E! Entertainment News, was diagnosed with breast cancer. It struck me as...
Oct 06, 2011
I am currently sitting with colleagues from across the country as we plan the 2012 Program, an honor and yet a daunting task! Searching pubmed, vetting potential speakers, and keeping abreast on office and business matters, I rely heavily on my laptop and web access, and dating back to 1986, I have...
Sep 24, 2011
I have followed with interest the exciting progress being made across oncology--progress in melanoma with the anti-CTLA agent iplimumab and the BRAF inhibitor,...

Pages